B-cell cultivation method

US10889802B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10889802-B2
Application numberUS-201816144240-A
CountryUS
Kind codeB2
Filing dateSep 27, 2018
Priority dateMar 30, 2016
Publication dateJan 12, 2021
Grant dateJan 12, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Herein is reported a method for co-cultivating one or more B-cells comprising the step of incubating the one or more B-cells with EL4-B5 cells, whereby the EL4-B5 cells have been obtained/are from a cultivation of EL4-B5 cells that has a cell density of from 600,000 cells/ml up to 1,500,000 cells/ml.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for co-cultivating one or more B-cells comprising the steps of cultivating EL4-B5 cells to a cell density of more than 1,000,000 cells/ml to 1,500,000 cells/ml, and incubating the one or more B-cells with an aliquot of the EL4-B5 cells obtained in the previous step. 2. The method according to claim 1 , wherein the cultivation of the EL4-B5 cells is to a cell density of 650,000 cells/ml to 1,450,000 cells/ml. 3. The method according to claim 1 , wherein the cultivation of the EL4-B5 cells is to a cell density of 1,400,000 cells/ml to 1,500,000 cells/ml. 4. The method according to claim 1 , wherein the incubating is additionally in the presence of a feeder mix. 5. The method according to claim 4 , wherein the feeder mix comprises one or more of: i) interleukin-1 beta and tumor necrosis factor alpha, ii) interleukin-2 (IL-2) and/or interleukin-10 (IL-10), iii) Staphylococcus aureus strain Cowan's cells (SAC), iv) interleukin-21 (IL-21) and optionally interleukin-2 (IL-2), v) B-cell activation factor of the tumor necrosis factor family (BAFF), vi) interleukin-6 (IL-6), vii) interleukin-4 (IL-4), and viii) thymocyte cultivation supernatant. 6. The method according to claim 4 , wherein the feeder mix comprises IL-1ß, TNF-α, IL-10 and one or more of the members selected from the group consisting of: IL-21, SAC, BAFF, IL-2, IL-4, and IL-6. 7. The method according to claim 1 , wherein the EL4-B5 cells are, after the cultivating and prior to the incubating, irradiated with y-radiation. 8. The method according to claim 1 , wherein the method is for the co-cultivation of one B-cell. 9. The method according to claim 8 , wherein the one B-cell is a single deposited B-cell. 10. The method according to claim 1 , wherein the incubating is for 5 to 14 days. 11. A method for producing an antibody, the method comprising performing the method according to claim 1 , thereby producing the antibody. 12. The method according to claim 11 , wherein the antibody is produced by the one or more B cells. 13. The method according to claim 12 , wherein the antibody is produced by the one or more B cells and secreted into cell culture supernatant. 14. The method according to claim 12 , further comprising recovering the antibody from the one or more B cells. 15. The method according to claim 13 , further comprising recovering the antibody from the cell culture supernatant.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10889802B2 cover?
Herein is reported a method for co-cultivating one or more B-cells comprising the step of incubating the one or more B-cells with EL4-B5 cells, whereby the EL4-B5 cells have been obtained/are from a cultivation of EL4-B5 cells that has a cell density of from 600,000 cells/ml up to 1,500,000 cells/ml.
Who is the assignee on this patent?
Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification C12N5/0635. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).